By 2030, the number of new cancer cases per year is expected to increase by 23.6 million worldwide. While radiation and chemotherapy continue to be crucial in the fight against cancer, researchers and clinicians have made significant progress in targeting this disease with immunotherapy.
What is the relationship between cancer and the immune system? How will immunotherapy continue to evolve? Dr. Malcolm Brenner, professor of molecular and human genetics and founding director of the Center for Cell and Gene Therapy at Baylor College of Medicine, discusses the science behind immunotherapy on the Body of Work podcast.
Listen to “Cell Wars” on your preferred platform.